Moreover, the significant negative correlations between ITGAE and CD69 gene expression and molecular markers of GBM (ITH2, ATRX, and TP53) suggest a possible anti-tumoral role for CD8+ TRM T lymphocytes, similar to that found in different tumors [26,27,28,29]. This evidence concerns the gene CD8A and glioblastoma.